Table 3_Unraveling life expectancy and death spectrum changes of registered residents (hukou) in Quzhou, China, 2015–2023: a study using Arriaga decomposition method.docx by Jie Pan (187977)

“…Age groups 55–80 made significant positive contributions, while 0- and 85- groups saw decreased contributions. …”

Table 5_Unraveling life expectancy and death spectrum changes of registered residents (hukou) in Quzhou, China, 2015–2023: a study using Arriaga decomposition method.docx by Jie Pan (187977)

“…Age groups 55–80 made significant positive contributions, while 0- and 85- groups saw decreased contributions. …”

Table 2_Unraveling life expectancy and death spectrum changes of registered residents (hukou) in Quzhou, China, 2015–2023: a study using Arriaga decomposition method.docx by Jie Pan (187977)

“…Age groups 55–80 made significant positive contributions, while 0- and 85- groups saw decreased contributions. …”

Table 1_Unraveling life expectancy and death spectrum changes of registered residents (hukou) in Quzhou, China, 2015–2023: a study using Arriaga decomposition method.docx by Jie Pan (187977)

“…Age groups 55–80 made significant positive contributions, while 0- and 85- groups saw decreased contributions. …”

Image 1_Unraveling life expectancy and death spectrum changes of registered residents (hukou) in Quzhou, China, 2015–2023: a study using Arriaga decomposition method.jpeg by Jie Pan (187977)

“…Age groups 55–80 made significant positive contributions, while 0- and 85- groups saw decreased contributions. …”

Table 4_Unraveling life expectancy and death spectrum changes of registered residents (hukou) in Quzhou, China, 2015–2023: a study using Arriaga decomposition method.docx by Jie Pan (187977)

“…Age groups 55–80 made significant positive contributions, while 0- and 85- groups saw decreased contributions. …”

Data Sheet 1_Disproportionality analysis of adverse events associated with pacritinib: a real-world study based on FDA Adverse Event Reporting System (FAERS) database.docx by Huiling Zhang (396342)

“…The aim of study is provided a comprehensive profile of pacritinib's safety by evaluating the adverse events (AEs) using a real-world pharmacovigilance database.…”

Image 4_Safety and efficacy of PD-1 inhibitors plus tyrosine kinase inhibitors combination therapy in patients with advanced hepatocellular carcinoma combined with hyperbilirubinem... by Shida Pan (12696593)

“…Multifactorial analysis showed that MELD score >18 and increased total bilirubin (TBIL) levels within one week were significant risk factors for OS. Patients with a decrease in TBIL levels within one week had significantly prolonged median OS (not reached vs 3.3months, P =0.013) and median PFS (7.03 months vs 2.77 months, P =0.010).…”

Image 2_Safety and efficacy of PD-1 inhibitors plus tyrosine kinase inhibitors combination therapy in patients with advanced hepatocellular carcinoma combined with hyperbilirubinem... by Shida Pan (12696593)

“…Multifactorial analysis showed that MELD score >18 and increased total bilirubin (TBIL) levels within one week were significant risk factors for OS. Patients with a decrease in TBIL levels within one week had significantly prolonged median OS (not reached vs 3.3months, P =0.013) and median PFS (7.03 months vs 2.77 months, P =0.010).…”

Table 2_Hyper-fractionated radiotherapy as a bridging strategy to enhance CAR-T efficacy by regulating T-cell co-stimulatory molecules in relapsed/refractory diffuse large B-cell l... by Jing Ruan (5117951)

“…After hyper-fractionated radiotherapy, peripheral PD1+CD8+T/T ratio significantly decreased while quantitative serum proteomics profiling showed a decrease in sCD28.…”

Table 1_Safety and efficacy of PD-1 inhibitors plus tyrosine kinase inhibitors combination therapy in patients with advanced hepatocellular carcinoma combined with hyperbilirubinem... by Shida Pan (12696593)

“…Multifactorial analysis showed that MELD score >18 and increased total bilirubin (TBIL) levels within one week were significant risk factors for OS. Patients with a decrease in TBIL levels within one week had significantly prolonged median OS (not reached vs 3.3months, P =0.013) and median PFS (7.03 months vs 2.77 months, P =0.010).…”

Table 1_Hyper-fractionated radiotherapy as a bridging strategy to enhance CAR-T efficacy by regulating T-cell co-stimulatory molecules in relapsed/refractory diffuse large B-cell l... by Jing Ruan (5117951)

“…After hyper-fractionated radiotherapy, peripheral PD1+CD8+T/T ratio significantly decreased while quantitative serum proteomics profiling showed a decrease in sCD28.…”

Table 3_Hyper-fractionated radiotherapy as a bridging strategy to enhance CAR-T efficacy by regulating T-cell co-stimulatory molecules in relapsed/refractory diffuse large B-cell l... by Jing Ruan (5117951)

“…After hyper-fractionated radiotherapy, peripheral PD1+CD8+T/T ratio significantly decreased while quantitative serum proteomics profiling showed a decrease in sCD28.…”

Image 3_Safety and efficacy of PD-1 inhibitors plus tyrosine kinase inhibitors combination therapy in patients with advanced hepatocellular carcinoma combined with hyperbilirubinem... by Shida Pan (12696593)

“…Multifactorial analysis showed that MELD score >18 and increased total bilirubin (TBIL) levels within one week were significant risk factors for OS. Patients with a decrease in TBIL levels within one week had significantly prolonged median OS (not reached vs 3.3months, P =0.013) and median PFS (7.03 months vs 2.77 months, P =0.010).…”

Image 1_Safety and efficacy of PD-1 inhibitors plus tyrosine kinase inhibitors combination therapy in patients with advanced hepatocellular carcinoma combined with hyperbilirubinem... by Shida Pan (12696593)

“…Multifactorial analysis showed that MELD score >18 and increased total bilirubin (TBIL) levels within one week were significant risk factors for OS. Patients with a decrease in TBIL levels within one week had significantly prolonged median OS (not reached vs 3.3months, P =0.013) and median PFS (7.03 months vs 2.77 months, P =0.010).…”

Data Sheet 4_Modeling the advective supply of Calanus finmarchicus to Stellwagen Bank as an indicator of sand lance foraging habitat, and the climate vulnerability of a National Ma... by Cameron R. S. Thompson (20622296)

“…Climate change poses a significant threat to this dynamic, as C. finmarchicus populations are at the southern edge of their subarctic distribution and are vulnerable to warming waters and changing oceanographic conditions. …”

Data Sheet 3_Modeling the advective supply of Calanus finmarchicus to Stellwagen Bank as an indicator of sand lance foraging habitat, and the climate vulnerability of a National Ma... by Cameron R. S. Thompson (20622296)

“…Climate change poses a significant threat to this dynamic, as C. finmarchicus populations are at the southern edge of their subarctic distribution and are vulnerable to warming waters and changing oceanographic conditions. …”

Data Sheet 2_Modeling the advective supply of Calanus finmarchicus to Stellwagen Bank as an indicator of sand lance foraging habitat, and the climate vulnerability of a National Ma... by Cameron R. S. Thompson (20622296)

“…Climate change poses a significant threat to this dynamic, as C. finmarchicus populations are at the southern edge of their subarctic distribution and are vulnerable to warming waters and changing oceanographic conditions. …”

Data Sheet 1_Modeling the advective supply of Calanus finmarchicus to Stellwagen Bank as an indicator of sand lance foraging habitat, and the climate vulnerability of a National Ma... by Cameron R. S. Thompson (20622296)

“…Climate change poses a significant threat to this dynamic, as C. finmarchicus populations are at the southern edge of their subarctic distribution and are vulnerable to warming waters and changing oceanographic conditions. …”

Table 1_Assessment of platelet-to-white blood cell ratio on short-term mortality events in patients hospitalized with acute decompensated heart failure: evidence from a cohort stud... by Xin Huang (11077)

“…Further threshold analysis revealed a threshold point for PWR at 15.88, where a decrease in PWR below this threshold was significantly associated with increased risk of all-cause mortality (p for log-likelihood ratio test = 0.046). …”